[Lamivudine treatment consensus from relative experts in 2003].
D000410:Alanine Transaminase / Q000097:blood / Q000187:drug effects; D000914:Antibodies, Viral / Q000097:blood; D000998:Antiviral Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006513:Hepatitis B e Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000187:drug effects* / Q000235:genetics / Q000276:immunology; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D007371:Interferon-gamma / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use*; D016133:Polymerase Chain Reaction; D014779:Virus Replication / Q000187:drug effects
D000914:Antibodies, Viral; D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D019259:Lamivudine; D007371:Interferon-gamma; D000410:Alanine Transaminase